期刊文献+

不同剂量瑞舒伐他汀的短期降脂效果及不良反应探究 被引量:2

Study on the short-term lipid-lowering effects and adverse reactions of different doses of rosuvastatin
下载PDF
导出
摘要 目的探究不同剂量瑞舒伐他汀的短期降脂效果及不良反应发生情况。方法50例血脂偏高患者,根据瑞舒伐他汀用药剂量的不同分为低剂量组和高剂量组,每组25例。两组患者均给予瑞舒伐他汀,低剂量组给予10 mg/d,高剂量组给予20 mg/d。比较两组患者短期降脂效果及不良反应发生情况。结果治疗后,两组患者的总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)水平均较治疗前下降,高密度脂蛋白胆固醇(HDL-C)水平较治疗前上升,且高剂量组的TC、TG、LDL-C水平低于低剂量组,HDL-C水平高于低剂量组,差异具有统计学意义(P<0.05)。高剂量组不良反应发生率36%高于低剂量组的12%,差异具有统计学意义(P<0.05)。结论高剂量瑞舒伐他汀(20 mg/d)的短期降脂效果更为确切,但用药后不良反应发生率较高,临床用药应根据患者病情合理选择用药剂量。 Objective To investigate the short-term lipid-lowering effects and adverse reactions of different doses of rosuvastatin.Methods A total of 50 patients with hyperlipidemia were divided into low-dose group and high-dose group according to the different dosage of rosuvastatin,with 25 cases in each group.Both groups received rosuvastatin for treatment,with 10 mg/d in the low-dose group and 20 mg/d in the high-dose group.The short-term lipid-lowering effects and occurrence of adverse reactions were compared between the two groups.Results After treatment,the total cholesterol(TC),triglycerides(TG),low-density lipoprotein cholesterol(LDL-C)of the two groups were lower than those before treatment,and high-density lipoprotein cholesterol(HDL-C)was higher than that before treatment.TC,TG and LDL-C of high-dose group were lower than those of low-dose group,and HDL-C was higher than that of low-dose group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions 36%of high-dose group was lower than that of low-dose group 12%,and the difference was statistically significant(P<0.05).Conclusion High-dose rosuvastatin(20 mg/d)has more accurate short-term lipid-lowering effect,but the incidence of adverse reactions is high,so the dosage of rosuvastatin should be selected according to the patient’s condition.
作者 朱桂军 ZHU Gui-jun(Department of Pharmacy,Xiangcheng District Caohu People’s Hospital,Suzhou 215000,China)
出处 《中国现代药物应用》 2020年第18期124-126,共3页 Chinese Journal of Modern Drug Application
关键词 瑞舒伐他汀 高血脂 不同剂量 降脂 不良反应 Rosuvastatin Hyperlipidemia Different doses Lipid lowering Adverse reactions
  • 相关文献

参考文献9

二级参考文献73

  • 1覃仁安,罗佳波,黄竹英,朱汀.复方丹参片实验研究及临床应用概况[J].中医杂志,2004,45(6):470-472. 被引量:20
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2143
  • 3中国药典.一部[S].北京:中国医药科技出版社,2010.
  • 4de Miguel A, Ibanez B, Badimon J J. Clinical implications of clopidogrel resistance [ J ]. Thromb Haemost ,2005,100 : 196.
  • 5Jefrey S B, Deepak L B, Christopher P C, et al. The relative efficacy and safety of clopidogrel in women andmen--A sex specific collaborative meta-analysis [ J ]. J Am ColI Cardio1,2009,54 : 1935.
  • 6Adriane F B. Herb-drug interactions [ J ]. Lancet,2000, 355 : 134.
  • 7Ara T J, Viqar M, Arshad J. Use of herbal products and potential interactions in patients with cardiovascular diseases[J~. J Am Coil Cardiol, 2010,55:515.
  • 8He J, Gu D, Wu X, et al. Major causes of death among men and women in China[J]. N Engl J Med, 2005,353 (11) :1124.
  • 9Mehta S R, Tanguay J F, Eikelboom J W, et al. Double-dose versus standard-dose clopidogrel and high- dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes ( CURRENT-OASIS 7 ): a randomised factorial trial[ J]. Lancet,2010,376 : 1233.
  • 10Ho P M, Maddox T M, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome[ J ]. JAMA ,2009,301:937.

共引文献30

同被引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部